Research Study for Eyelash Growth

You may qualify to participate in a clinical research study involving the investigational use of bimatoprost (Lumigan ®) ophthalmic drops in promoting eyelash growth in patients with eyelash loss due to alopecia areata. Bimatatoprost ophthalmic solution is approved for the treatment of glaucoma. Patients who are treated for glaucoma with this medication often notice longer, thicker eyelashes. Currently, there are no safe or acceptable treatments for eyelash loss due to alopecia areata.

You may qualify to participate in this study if you:
• Are between the ages of 18 – 70
• Have 50% or more eyelash loss in both eyes due to alopecia areata which has been
present for 6 months or longer.

All office visits, ophthalmologic examinations, photographs, and study drug will be provided without charge. There is no compensation for time or travel.

If you live in the vicinity of the location listed below and would like to find out if you qualify to be a participant, or if you have further questions about this study, please call the investigator below.

Investigator Location Contact
Vera H. Price, M.D. University of California, San Francisco
San Francisco, CA Blanca E. Ochoa, M.D.
(415) 353-9529
Email: [email protected][email protected]

Speak Your Mind

This site uses Akismet to reduce spam. Learn how your comment data is processed.